These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5353959)

  • 21. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women.
    Drill VA
    J Reprod Med; 1980 Jan; 24(1):5-13. PubMed ID: 6987399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The mechanism of action of oral contraceptives].
    Manuilova IA
    Akush Ginekol (Mosk); 1971 Feb; 47(2):3-8. PubMed ID: 4940751
    [No Abstract]   [Full Text] [Related]  

  • 25. U.S. Food and Drug Administration requirements for toxicity testing of contraceptive products.
    Berliner VR
    Acta Endocrinol Suppl (Copenh); 1974; 185():240-65. PubMed ID: 4206185
    [No Abstract]   [Full Text] [Related]  

  • 26. [Gestagen induced mammary tumors in dog--hardly relevant for human medicine].
    Christoffersen T
    Tidsskr Nor Laegeforen; 1980 Jan; 100(1):34. PubMed ID: 7368190
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Shapiro S
    Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
    [No Abstract]   [Full Text] [Related]  

  • 28. Special problems in toxicity testing of long acting depot contraceptives.
    Neumann F; Berswordt-Wallrabe R VO; Elger W; Gräf KJ; Hasan SH; Mehring M; Nishino Y; Steinbeck H
    Acta Endocrinol Suppl (Copenh); 1974; 185():315-54. PubMed ID: 4206188
    [No Abstract]   [Full Text] [Related]  

  • 29. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
    Nomura A; Comstock GW
    Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of studies on estrogens, oral contraceptives and breast cancer.
    Drill VA
    Prog Drug Res; 1981; 25():159-87. PubMed ID: 6796999
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of rodents for studies of toxicity in contraceptive research.
    Leonard BJ
    Acta Endocrinol Suppl (Copenh); 1974; 185():34-73. PubMed ID: 4593797
    [No Abstract]   [Full Text] [Related]  

  • 32. Breast cancer and oestrogen content of oral contraceptives.
    Bye P
    Lancet; 1984 Jan; 1(8370):223. PubMed ID: 6141361
    [No Abstract]   [Full Text] [Related]  

  • 33. Mammary carcinogenesis in female and male mice receiving contraceptives or gestagens.
    Rudali G; Coezy E; Chemama R
    J Natl Cancer Inst; 1972 Sep; 49(3):813-9. PubMed ID: 4119120
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral contraceptives. Assessment of benefits.
    Derman R
    J Reprod Med; 1986 Sep; 31(9 Suppl):879-86. PubMed ID: 3772907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral contraceptives and menopausal estrogens in relation to breast neoplasia].
    Brzezinski A; Schenker JG
    Harefuah; 1983 Jun; 104(11-12):520-3. PubMed ID: 6680711
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oral contraception: uncertainties and prospects].
    Mauvais-Jarvis P
    Rev Prat; 1978 Sep; 28(41):3143-6, 3149-50, 3153-6. PubMed ID: 715351
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral contraceptives and breast cancer: what has 20 years of research shown?
    Buehring GC
    Biomed Pharmacother; 1988; 42(8):525-30. PubMed ID: 3066414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of endogenous and exogenous reproductive hormones on the mammary glands with emphasis on experimental studies in rhesus monkeys.
    Tavassoli FA
    Verh Dtsch Ges Pathol; 1997; 81():514-20. PubMed ID: 9474892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contraceptives and breast cancer (author's transl)].
    Mauvais-Jarvis P; Kuttenn F
    Contracept Fertil Sex (Paris); 1976 Sep; 4(5):343-8. PubMed ID: 992191
    [No Abstract]   [Full Text] [Related]  

  • 40. Estrogens and breast cancer.
    Blander CL
    N Engl J Med; 2006 Apr; 354(15):1647-8; author reply 1647-8. PubMed ID: 16611962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.